Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
3.380
-0.100 (-2.87%)
At close: May 12, 2025, 4:00 PM
3.380
0.00 (0.00%)
After-hours: May 12, 2025, 4:20 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $63.21 million as of May 12, 2025.
Market Cap
63.21M
Enterprise Value
83.35M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $63.21M, a decrease of -70.53%. That is a compound annual growth rate of -99.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 65.08M | -69.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |